Q2 2024 · 13F-HR/A
Birchview Capital, LPholdings as filed
Filed 2025-06-30 · accession 0001618205-25-000006
$108.2M
Reported value
60
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 110122108 | BMY | BRISTOL-MYERS SQUIBB CO | $28.6M | 26.4% | 688,218 | Common | SOLE |
| 09075X108 | — | BIODESIX INC COM RST | $8.7M | 8.04% | 5,696,113 | Common | SOLE |
| 05479K106 | ELUT | ELUTIA INC | $7.7M | 7.11% | 1,551,655 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $5.8M | 5.37% | 42,240 | Common | SOLE |
| 82710M100 | SILKUSD | SILK ROAD MEDICAL INC | $4.3M | 3.95% | 158,094 | Common | SOLE |
| G72800108 | PRTA | PROTHENA CORP PLC | $4.2M | 3.88% | 203,574 | Common | SOLE |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $4.1M | 3.76% | 250,400 | Common | SOLE |
| 69047Q102 | OVV | OVINTIV INC | $3.5M | 3.21% | 74,200 | Common | SOLE |
| 91307C102 | UTHR | UNITED THERAPEUTICS CORP | $3.2M | 2.94% | 10,000 | Common | SOLE |
| 415858109 | HROW | HARROW HEALTH INC | $3.1M | 2.90% | 150,000 | Common | SOLE |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $2.8M | 2.62% | 210,000 | Common | SOLE |
| 71944F106 | PHR | PHREESIA INC | $2.4M | 2.25% | 114,700 | Common | SOLE |
| 218352102 | CORT | CORCEPT THERAPEUTICS INC | $2.4M | 2.22% | 74,000 | Common | SOLE |
| 74838J101 | — | QUIDELORTHO CORP | $2.2M | 2.08% | 67,619 | Common | SOLE |
| 574795100 | MASI | MASIMO CORP | $1.9M | 1.78% | 15,280 | Common | SOLE |
| 344174107 | FHTX | FOGHORN THERAPEUTICS INC | $1.8M | 1.71% | 320,930 | Common | SOLE |
| 294600101 | ETRNUSD | EQUITRANS MIDSTREAM CORPORATIO | $1.7M | 1.60% | 133,050 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $1.7M | 1.54% | 48,000 | Common | SOLE |
| 05463X106 | AXGN | AXOGEN INC | $1.4M | 1.32% | 197,000 | Common | SOLE |
| 256086109 | DCGO | DOCGO INC | $1.4M | 1.31% | 460,000 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $1.2M | 1.11% | 50,000 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $1.0M | 0.93% | 122,000 | Common | SOLE |
| 02081G201 | ATEC | ALPHATEC HOLDINGS INC | $919,600 | 0.85% | 88,000 | Common | SOLE |
| 14843C105 | CSTL | CASTLE BIOSCIENCES INC | $740,180 | 0.68% | 34,000 | Common | SOLE |
| 30231G102 | XOM | EXXON MOBIL CORP | $673,332 | 0.62% | 5,849 | Common | SOLE |
| 74340E103 | PGNY | PROGYNY INC | $629,420 | 0.58% | 22,000 | Common | SOLE |
| 88025U109 | TXG | 10X GENOMICS INC | $583,500 | 0.54% | 30,000 | Common | SOLE |
| G5269C101 | — | KINIKSA PHARMACEUTICALS LTD | $560,100 | 0.52% | 30,000 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $541,880 | 0.50% | 46,000 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $541,800 | 0.50% | 10,000 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $537,040 | 0.50% | 14,000 | Common | SOLE |
| 40637H109 | HALO | HALOZYME THERAPEUTICS INC | $523,600 | 0.48% | 10,000 | Common | SOLE |
| 19249H103 | CHRS | COHERUS BIOSCIENCES INC | $467,100 | 0.43% | 270,000 | Common | SOLE |
| 48576U106 | KPTIEUR | KARYOPHARM THERAPEUTICS INC | $407,626 | 0.38% | 469,832 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $399,300 | 0.37% | 15,000 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $395,000 | 0.37% | 2,500 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $389,900 | 0.36% | 10,000 | Common | SOLE |
| 00430H102 | — | ACCELERATE DIAGNOSTICS INC | $380,529 | 0.35% | 325,239 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $376,700 | 0.35% | 10,000 | Common | SOLE |
| 230031106 | CGEM | CULLINAN ONCOLOGY INC | $348,800 | 0.32% | 20,000 | Common | SOLE |
| G6674U108 | NVCR | NOVOCURE LTD | $342,600 | 0.32% | 20,000 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $322,000 | 0.30% | 4,000 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $319,900 | 0.30% | 7,000 | Common | SOLE |
| 09609G100 | — | BLUEBIRD BIO INC | $306,283 | 0.28% | 311,200 | Common | SOLE |
| 03152W109 | AM6 | AMICUS THERAPEUTICS INC | $277,760 | 0.26% | 28,000 | Common | SOLE |
| G11196105 | — | BIOHAVEN PHARMACEUTICAL HOLDING CO LTD | $255,639 | 0.24% | 7,365 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $247,200 | 0.23% | 40,000 | Common | SOLE |
| 98401F105 | XNCR | XENCOR INC | $232,839 | 0.22% | 12,300 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $199,600 | 0.18% | 40,000 | Common | SOLE |
| 3621LQ109 | GTHXEUR | G1 THERAPEUTICS INC | $182,400 | 0.17% | 80,000 | Common | SOLE |
| 45720N103 | INBX | INHIBRX BIOSCIENCES INC | $170,586 | 0.16% | 12,110 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $124,483 | 0.12% | 138,176 | Common | SOLE |
| 53635D202 | LQDA | LIQUIDIA CORPORATION | $120,000 | 0.11% | 10,000 | Common | SOLE |
| N44821101 | IFRX | INFLARX NV | $87,000 | 0.08% | 50,000 | Common | SOLE |
| 12674W109 | CABA | CABALETTA BIO INC | $74,800 | 0.07% | 10,000 | Common | SOLE |
| 901384107 | TSVT* | 2SEVENTY BIO INC | $68,657 | 0.06% | 17,833 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $66,528 | 0.06% | 28,800 | Common | SOLE |
| 98943L107 | ZNTL | ZENTALIS PHARMACEUTICALS INC | $65,440 | 0.06% | 16,000 | Common | SOLE |
| 690145107 | OMGBP | OUTSET MEDICAL INC | $38,500 | 0.04% | 10,000 | Common | SOLE |
| 71902K105 | — | CERO THERAPEUTICS HOLDINGS INC | $3,879 | 0.00% | 12,972 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.